Radiopharm Theranostics Statistics
NASDAQ: RADXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.6304-0.0678 (-9.71%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Radiopharm Theranostics by the numbers
Radiopharm Theranostics has a market capitalization of $9.9 million based on 15.70M shares outstanding. With trailing EPS of $-3.64, Radiopharm Theranostics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 45.4% below its 50-day average and 81.2% below its 200-day average.
Average daily trading volume is 55.23K shares, or about $34,814 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RADX valuation vs. peer median
| Metric | RADX | Peer median | Difference |
|---|---|---|---|
| Market cap | $9.90M | $9.26M | +7% |
| Avg. volume | 55.23K | 91.27K | -39% |
Peer median across 8 companies: ASBP, CMMB, BFRI, AEON, GDTC, CALC, OPTH, BIVI.
Valuation
- Market cap
- $9.90M
- Price / sales (latest FY)
- 2.72
- EPS (TTM)
- $-3.64
- Shares outstanding
- 15.70M
Price and trading
- Previous close
- 0.6982
- Open
- 0.7159
- Day range
- 0.63 – 0.716
- 52-week range
- 0.63 – 16.25
- 52-week change
- -86.15%
- Beta
- —
- Volume
- 12.98K
- Average volume
- 55.23K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 9.90M
- Forward Pe
- -0.27
- Eps
- -3.64
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 16.25
- Week52 Low
- 0.63
- Avg Volume
- 55,225.00
- Shares Outstanding
- 15.70M
- Ma50
- 1.15
- Ma200
- 3.36
- Pct From52w High
- -96.12%
- Pct From52w Low
- 0.06%